Stay updated on Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.4.2 in the footer, replacing the previous Revision: v3.4.1. No other content or functionality appears to be affected; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T17:52:11.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.4.0 to v3.4.1. No other visible content changes were detected.
    Difference
    0.1%
    Check dated 2026-02-06T11:28:37.000Z thumbnail image
  4. Check
    19 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1 replacing Revision: v3.4.0; this is a minor administrative update and does not affect trial details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T13:23:22.000Z thumbnail image
  5. Check
    27 days ago
    Change Detected
    Summary
    Show glossary toggle has been added, along with new metadata labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision 'v3.4.0'. The old labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.
    Difference
    0.2%
    Check dated 2026-01-29T06:58:40.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to study content or user-facing features detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T02:46:23.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Location details were updated to include North Carolina under the Locations section, replacing the previous North Carolina Locations listing. The HHS Vulnerability Disclosure link was removed in this revision.
    Difference
    0.2%
    Check dated 2025-12-24T16:29:44.000Z thumbnail image

Stay in the know with updates to Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.